Literature DB >> 140642

Valproate sodium in Huntington chorea.

I Pearce, K W Heathfield, M J Pearce.   

Abstract

An open trial of valproate sodium in 14 patients suffering from Huntington chorea showed that the drug was ineffective in the two treatment schedules employed.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 140642     DOI： 10.1001/archneur.1977.00500170062012

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


  8 in total

Review 1.  Pharmacology of epigenetics in brain disorders.

Authors:  Pritika Narayan; Mike Dragunow
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

Review 2.  Molecular and therapeutic potential and toxicity of valproic acid.

Authors:  Sébastien Chateauvieux; Franck Morceau; Mario Dicato; Marc Diederich
Journal:  J Biomed Biotechnol       Date:  2010-07-29

3.  Quantitative evaluation of functional capacity during isoniazid therapy in Huntington's disease.

Authors:  T Stober; K Schimrigk; G Holzer; B Ziegler
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

Review 4.  Symptomatic treatment of Huntington disease.

Authors:  Octavian R Adam; Joseph Jankovic
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

5.  Targeting Huntington's disease through histone deacetylases.

Authors:  Steven G Gray
Journal:  Clin Epigenetics       Date:  2011-02-18       Impact factor: 6.551

6.  Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series.

Authors:  Carsten Saft; Thorsten Lauter; Peter H Kraus; Horst Przuntek; Juergen E Andrich
Journal:  BMC Neurol       Date:  2006-02-28       Impact factor: 2.474

7.  Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors.

Authors:  Elizabeth A Thomas
Journal:  Pharmaceuticals (Basel)       Date:  2014-05-26

Review 8.  Preclinical and clinical investigations of mood stabilizers for Huntington's disease: what have we learned?

Authors:  Lisa Scheuing; Chi-Tso Chiu; Hsiao-Mei Liao; Gabriel R Linares; De-Maw Chuang
Journal:  Int J Biol Sci       Date:  2014-09-10       Impact factor: 6.580
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.